It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
“all the SSRIs [including Prozac and Luvox] relieve the patient of feeling. He becomes less empathic, as in `I don’t care as much,’ which means `It’s easier for me to harm you.’ If a doctor treats someone who needs a great deal of strength just to think straight, and gives him one of these drugs, that could push him over the edge into violent behavior.”
“six depressed patients, previously free of recent suicidal ideation, who developed `intense, violent suicidal preoccupations after 2-7 weeks of fluoxetine [Prozac] treatment.’ The suicidal preoccupations lasted from three days to three months after termination of the treatment. The report estimates that 3.5 percent of Prozac users were at risk.
What I came to call a “Johnny Appleseed specter” loomed over America. If psychiatrists dispensed enough of these drugs, seeding the population, we would be in for random shootings and killings and suicides on into the indefinite future. And psychiatrists were, in fact, handing out these drugs like candy. No one at the FDA or any enforcement government agency was ringing alarm bells.
In the ensuing years, I became much more aware of the influence of drug companies in this Johnny Appleseed operation. They had, in fact, struck a deal to rescue the sinking profession of psychiatry. The arrangement was simple and potent: Big Pharma would bankroll psychiatric conferences and education, prop up flagging journals with advertising money, and generally promote the repute of psychiatry, in return for a certain kind of research:
The research would “prove” that all mental disorders were the result of chemical imbalances in the brain, and no amount of talk therapy would resolve these issues. Instead, it would take drugs, which of course would be developed and sold by Pharma.
Originally posted by acmpnsfal
reply to post by FortAnthem
This whole medications creates mass killers theory is nonsense. Mass murderers have been around since we have recorded history, long before these drugs were developed. ...
Psychiatric Meds: Prescription for Murder?
These medicines act on the body’s nervous system — altering its chemical communication pathways to affect areas of the brain involved in judgment, abstract reasoning, memory, emotions, and the fight-or-flight response — explains Michelle Morrison-Valfre, MHS, FNP in her 2005 book, Foundations of Mental Health Care. The expected result is a calm mood and clear thinking. However, in some cases unexpected results occur.
The Physicians’ Desk Reference (PDR), an authoritative source of all FDA-approved drug labeling information, identifies the potential hazardous side effects of psychotherapeutics, including suicidal and homicidal ideation. Unfortunately, such effects are not uncommon. In fact, when taking a particular medication poses serious risks, the FDA requires drug manufacturers to highlight the dangers in eye-catching boxes on pharmaceutical packaging. A drug’s “black box warning” alerts consumers to the major hazards they face when taking that medicine. Most prescriptions do not have black box warnings — only those that can cause extreme adverse reactions compared to the potential benefit.
Angell relates that psychiatric treatment shifted from “talk therapy” to drug therapy in the 1950s when doctors noticed new drugs meant to treat infections also “blunted disturbing mental symptoms” by affecting the levels of certain chemicals in the brain. Out of that observation was born the theory that mental illness is a result of chemical imbalances. “Thus, instead of developing a drug to treat an abnormality, an abnormality was postulated to fit a drug,” observed Angell. “That was a great leap in logic.” She noted that subsequent studies have proven such chemical imbalances do not in fact exist in patients diagnosed with psychiatric disorders such as depression. It is only after a person takes a psychiatric medication that the brain begins to function abnormally.
The advent of these drugs coincides disturbingly with a rise in the adolescent suicide rate. Ritalin was introduced in 1956. Antidepressants made their debut in the early 1960s, according to Morrison-Valfre, who noted elsewhere in her text that statistics from the U.S. Bureau of the Census reveal, “from 1960 to 2000 the rate of adolescent suicide more than doubled.” This may be coincidental, but it is unnerving in light of these drugs’ well-known adverse effects.
One thing, however, is certain. Prior to the advent of antidepressants, there was little relation between depression and violent behavior. “One of the things in the past that we’ve known about depression is that it very, very rarely leads to violence,” observed psychiatrist Peter Breggin in a Fox News report. “It’s only been since the advent of these new SSRI drugs that we have murderers, sometimes even mass murderers, taking antidepressant drugs.”
Moreover, diagnosing mental illness is largely a subjective endeavor, unlike other fields of medicine that rely on objective lab data or scans and x-rays for diagnosis. So says psychiatrist Daniel Carlat in his 2010 book Unhinged: The Trouble With Psychiatry — A Doctor’s Revelations About a Profession in Crisis. “Our diagnoses are subjective and expandable, and we have few rational reasons for choosing one treatment over another,” admits Carlat.
Eager to exploit the benefits of the chemical theory and aware of the “subjective and expandable” nature of diagnosing mental illness, drug companies vigorously subsidize the psychiatric profession. In his 2010 exposé Anatomy of an Epidemic, Robert Whitaker notes that besides the gifts and fringe benefits given directly to psychiatrists, especially those at influential academic centers, drug companies generously support psychiatric associations, patient advocacy groups, and educational organizations. They fund around one-fifth of the budget of the American Psychiatric Association. In the first quarter of 2009 alone, pharmaceutical company Eli Lilly donated more than $1.2 million to mental health non-profits.
Angell goes on to explain how drug companies peddle their wares. In order to have a drug approved, pharmaceutical manufacturers must submit to the FDA two clinical trials proving a product more effective than a placebo. Drug companies can perform as many trials as they wish in order to achieve the two successful tests they need. Positive studies are highly publicized while the negative are suppressed. In a review of tests for the six most widely used antidepressants between 1987 and 1999 — Prozac, Paxil, Zoloft, Celexa, Serzone, and Effexor — Angell reported, “Most of them were negatives. Overall, placebos were 82 percent as effective as the drugs.… The average difference between drug and placebo … was clinically meaningless.”